IP Library Granted Patent US 7,749,518
Granted Patent B2
US 7,749,518 · App. 11/596,557 · Granted Jul 6, 2010

Polypeptides from non-typeable

Assignee: Novartis Vaccines and Diagnostics SRL
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,749,518
App. No.
11/596,557
Granted
Jul 6, 2010
Kind
B2
Abstract

Polypeptides comprising non-typeable Haemophilus influenzae (NTHi) amino acid sequences. Over 2500 specific NTHi proteins are disclosed. The invention also provides related polypeptides, nucleic acids, antibodies and methods. These can all be used in medicine for treating or preventing disease and/or infection caused by H. influenzae , such as otitis media.

Claims (6)

1. An isolated, immunogenic polypeptide comprising an amino acid sequence with at least 95% sequence identity to the sequence of SEQ ID NO:2368.

2. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence of SEQ ID NO:2368.

3. A composition comprising: (a) polypeptide of claim 1 ; and (b) a pharmaceutically acceptable carrier.

4. The composition of claim 3 , further comprising an adjuvant.

5. A composition comprising: (a) polypeptide of claim 2 ; and (b) a pharmaceutically acceptable carrier.

6. The composition of claim 5 , further comprising an adjuvant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2016
From: NOVARTIS VACCINES AND DIAGNOSTICS SRL
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 040078/0090 →
Priority Claims (1)
GB 0410866.8 · May 14, 2004 · national
Continuity (1)
Related Publication 20080267966A1 · Oct 30, 2008